• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吸烟作为手术切除的早期原发性肝细胞癌极晚期复发的一个危险因素。

Smoking as a Risk Factor for Very Late Recurrence in Surgically Resected Early-Stage Primary Hepatocellular Carcinoma.

作者信息

Cho Wei-Ru, Wang Chih-Chi, Tsai Mu-Jung, Lin Chih-Che, Yen Yi-Hao, Chen Chien Hung, Kuo Yuan-Hung, Yao Chih-Chien, Hung Chao-Hung, Huang Pao-Yuan, Liu An-Che, Tsai Ming-Chao

机构信息

Department of Hepato-Gastroenterology, Chang Gung Memorial Hospital, Yunlin.

Division of General Surgery, Department of Surgery, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung.

出版信息

Clin Med Insights Oncol. 2024 Mar 5;18:11795549241228232. doi: 10.1177/11795549241228232. eCollection 2024.

DOI:10.1177/11795549241228232
PMID:38450293
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10916494/
Abstract

BACKGROUND

The risk of first recurrence of hepatocellular carcinoma (HCC) within years 5 to 10 after curative hepatectomy remains unknown. We aimed to assess the incidence and prognostic factors for very late recurrence among patients who achieved 5 years' recurrence-free survival (RFS) after primary resection.

METHODS

We retrospectively analyzed 337 patients with early-stage HCC underwent primary tumor resection and achieved more than 5 years' RFS.

RESULTS

A total of 77 patients (22.8%) developed very late recurrence. The cumulative very late recurrence rate increased from 6.9% and 11.7% to 16.6% at 6, 7, and 8 years, respectively. Patients stopped smoking had a higher rate of very late RFS.

CONCLUSIONS

The high rates of very late recurrence in HCC indicate that patients warrant continued surveillance, even after 5 recurrence-free years. Moreover, smoking is a risk factor for very late HCC recurrence, and quitting smoking may reduce the risk of very late recurrence.

摘要

背景

肝细胞癌(HCC)根治性肝切除术后5至10年内首次复发的风险尚不清楚。我们旨在评估初次切除术后实现5年无复发生存(RFS)的患者中极晚期复发的发生率及预后因素。

方法

我们回顾性分析了337例行原发性肿瘤切除且实现超过5年RFS的早期HCC患者。

结果

共有77例患者(22.8%)发生极晚期复发。极晚期复发累积率在第6、7和8年分别从6.9%和11.7%升至16.6%。戒烟患者的极晚期RFS率更高。

结论

HCC极晚期复发率高表明,即使在5年无复发后,患者仍需继续监测。此外,吸烟是HCC极晚期复发的危险因素,戒烟可能降低极晚期复发风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1383/10916494/477a162034d5/10.1177_11795549241228232-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1383/10916494/4fa2b22d2951/10.1177_11795549241228232-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1383/10916494/c4790280c598/10.1177_11795549241228232-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1383/10916494/2305a79c9185/10.1177_11795549241228232-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1383/10916494/477a162034d5/10.1177_11795549241228232-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1383/10916494/4fa2b22d2951/10.1177_11795549241228232-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1383/10916494/c4790280c598/10.1177_11795549241228232-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1383/10916494/2305a79c9185/10.1177_11795549241228232-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1383/10916494/477a162034d5/10.1177_11795549241228232-fig4.jpg

相似文献

1
Smoking as a Risk Factor for Very Late Recurrence in Surgically Resected Early-Stage Primary Hepatocellular Carcinoma.吸烟作为手术切除的早期原发性肝细胞癌极晚期复发的一个危险因素。
Clin Med Insights Oncol. 2024 Mar 5;18:11795549241228232. doi: 10.1177/11795549241228232. eCollection 2024.
2
Volumetric parameters on FDG PET can predict early intrahepatic recurrence-free survival in patients with hepatocellular carcinoma after curative surgical resection.FDG PET 的容积参数可预测肝癌患者根治性手术后的早期肝内无复发生存。
Eur J Nucl Med Mol Imaging. 2017 Nov;44(12):1984-1994. doi: 10.1007/s00259-017-3764-7. Epub 2017 Jul 11.
3
Preoperative inflammation-based markers predict early and late recurrence of hepatocellular carcinoma after curative hepatectomy.术前基于炎症的标志物可预测根治性肝切除术后肝细胞癌的早期和晚期复发。
Hepatobiliary Pancreat Dis Int. 2016 Jun;15(3):266-74. doi: 10.1016/s1499-3872(16)60094-2.
4
Early and Late Recurrence of Hepatitis B Virus-Associated Hepatocellular Carcinoma.乙肝病毒相关性肝细胞癌的早发和晚发复发。
Oncologist. 2020 Oct;25(10):e1541-e1551. doi: 10.1634/theoncologist.2019-0944. Epub 2020 Jun 9.
5
Repeat hepatectomy versus microwave ablation for solitary and small (≤3 cm) recurrent hepatocellular carcinoma with early or late recurrence: A propensity score matched study.肝切除与微波消融治疗早期或晚期复发的孤立性小(≤3 cm)复发性肝细胞癌的倾向评分匹配研究
Eur J Surg Oncol. 2023 May;49(5):1001-1008. doi: 10.1016/j.ejso.2022.12.016. Epub 2022 Dec 26.
6
The Impact of Direct-Acting Antiviral Therapy on the Risk of Recurrence after Curative Resection in Patients with Hepatitis-C-Virus-Related Early Stage Hepatocellular Carcinoma.直接作用抗病毒治疗对丙型肝炎病毒相关早期肝细胞癌根治性切除术后复发风险的影响。
Medicina (Kaunas). 2022 Feb 9;58(2):259. doi: 10.3390/medicina58020259.
7
[Surgical treatment of primary liver cancer:a report of 10 966 cases].[原发性肝癌的外科治疗:10966例报告]
Zhonghua Wai Ke Za Zhi. 2021 Jan 1;59(1):6-17. doi: 10.3760/cma.j.cn112139-20201110-00791.
8
The ALBI Grade is a Good Predictive Model for Very Late Recurrence in Patients with Hepatocellular Carcinoma Undergoing Primary Resection.ALBI 分级是预测原发性肝癌切除术后极晚期复发的良好预测模型。
World J Surg. 2020 Jan;44(1):247-257. doi: 10.1007/s00268-019-05197-3.
9
Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma.肝细胞癌切除术后早期和晚期肝内复发的不同危险因素及预后
Cancer. 2000 Aug 1;89(3):500-7.
10
Impact of HBsAg seroclearance on late recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection.HBsAg 血清学清除对乙型肝炎病毒相关肝细胞癌切除术后晚期复发的影响。
J Hepatol. 2022 Oct;77(4):939-946. doi: 10.1016/j.jhep.2022.05.014. Epub 2022 May 26.

引用本文的文献

1
Roles of long non‑coding RNA SNHG16 in human digestive system cancer (Review).长链非编码 RNA SNHG16 在人类消化系统癌症中的作用(综述)。
Oncol Rep. 2024 Aug;52(2). doi: 10.3892/or.2024.8765. Epub 2024 Jun 28.

本文引用的文献

1
Cancer statistics, 2023.癌症统计数据,2023 年。
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
2
Analyses of P16 gene promoter methylation relative to molecular, demographic and clinical parameters characteristics in non-small cell lung cancer patients: A pilot study.分析非小细胞肺癌患者 P16 基因启动子甲基化与分子、人口统计学和临床参数特征的关系:一项初步研究。
Mol Biol Rep. 2023 Feb;50(2):971-979. doi: 10.1007/s11033-022-07982-1. Epub 2022 Nov 15.
3
Hepatocellular carcinoma.肝细胞癌。
Nat Rev Dis Primers. 2021 Jan 21;7(1):6. doi: 10.1038/s41572-020-00240-3.
4
Telomere length is key to hepatocellular carcinoma diversity and telomerase addiction is an actionable therapeutic target.端粒长度是肝细胞癌异质性的关键,而端粒酶依赖性是一个可实施的治疗靶点。
J Hepatol. 2021 May;74(5):1155-1166. doi: 10.1016/j.jhep.2020.11.052. Epub 2020 Dec 15.
5
Multiomic analysis of cytokines in immuno-oncology.免疫肿瘤学中细胞因子的多组学分析。
Expert Rev Proteomics. 2020 Sep;17(9):663-674. doi: 10.1080/14789450.2020.1845654. Epub 2020 Nov 23.
6
Substantial risk of recurrence even after 5 recurrence-free years in early-stage hepatocellular carcinoma patients.即使在早期肝细胞癌患者无复发 5 年后,仍存在复发的重大风险。
Clin Mol Hepatol. 2020 Oct;26(4):516-528. doi: 10.3350/cmh.2020.0016. Epub 2020 Sep 11.
7
Accidental Use of Milk With an Increased Concentration of Aflatoxins Causes Significant DNA Damage in Hospital Workers Exposed to Ionizing Radiation.误食高浓度黄曲霉毒素的牛奶会导致接触电离辐射的医院工作人员的 DNA 受到显著损伤。
Front Public Health. 2020 Jul 24;8:323. doi: 10.3389/fpubh.2020.00323. eCollection 2020.
8
Association between Smoking and Liver Fibrosis among Patients with Nonalcoholic Fatty Liver Disease.吸烟与非酒精性脂肪性肝病患者肝纤维化的关系。
Can J Gastroenterol Hepatol. 2019 Oct 15;2019:6028952. doi: 10.1155/2019/6028952. eCollection 2019.
9
Distribution of EGFR SNPs -191C/A and 181946G/A in patients with lung cancer depending on smoking status in the Republic of Srpska, Bosnia and Herzegovina.波斯尼亚和黑塞哥维那斯普斯卡共和国肺癌患者中表皮生长因子受体单核苷酸多态性-191C/A和181946G/A根据吸烟状况的分布情况。
J BUON. 2018 Mar-Apr;23(2):384-390.
10
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.欧洲肝脏研究学会临床实践指南:肝细胞癌的管理
J Hepatol. 2018 Jul;69(1):182-236. doi: 10.1016/j.jhep.2018.03.019. Epub 2018 Apr 5.